D
Diversified Healthcare Trust DHC
$6.72 -$0.15-2.18% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
--
EPS (TTM)

Company Overview

Diversified Healthcare Trust (DHC) is a publicly traded real estate investment trust (REIT) focused on owning, leasing, and financing healthcare-related properties. The company operates within the healthcare real estate and senior living industries, with assets spanning senior housing communities, medical office buildings, life science properties, and other healthcare facilities. DHC generates revenue primarily through rental income and management agreements with third-party operators across its diversified property portfolio.

DHC’s primary business lines include Senior Housing, Medical Office Buildings, and Life Science Properties, serving senior living operators, healthcare providers, research institutions, and life science companies. The trust emphasizes diversification by property type, operator, and geography, which it positions as a strategic advantage in mitigating sector-specific risks. Originally founded in 1999 as Senior Housing Properties Trust, the company expanded beyond senior housing through acquisitions and portfolio diversification and rebranded as Diversified Healthcare Trust in 2017 to reflect its broader healthcare real estate focus.

Business Operations

DHC operates through multiple business segments aligned with its property types, with revenue derived from lease payments, resident fees (through managed senior housing), and long-term tenancy agreements. Its Senior Housing Operating Portfolio includes independent living, assisted living, memory care, and skilled nursing facilities, many of which are operated under management agreements rather than triple-net leases. The Medical Office Buildings segment consists of outpatient facilities and physician offices, typically leased to healthcare systems and medical practices. The Life Science Properties segment includes laboratory and research facilities leased to biotechnology and pharmaceutical companies.

The company owns properties across the United States and maintains limited international exposure. DHC is externally managed by The RMR Group, which provides management, advisory, and administrative services. The trust does not directly operate healthcare services but relies on third-party operators and tenants. Its portfolio includes numerous wholly owned subsidiaries that hold individual properties, while joint ventures are used selectively to manage capital exposure and operational risk.

Strategic Position & Investments

DHC’s strategic direction centers on stabilizing cash flows, improving property performance, and selectively investing in higher-growth healthcare real estate sectors. Growth initiatives have included reallocating capital toward medical office and life science assets, which historically demonstrate stronger tenant credit profiles and demand fundamentals compared to senior housing. The company has also pursued asset sales and portfolio optimization to reduce leverage and improve balance sheet flexibility.

Major investments and acquisitions have historically focused on expanding its Life Science Properties platform and modern medical office facilities, while reducing exposure to underperforming senior housing assets. Notable subsidiaries primarily function as property-holding entities rather than operating companies. DHC has indicated interest in emerging healthcare delivery models and research-driven real estate, though disclosures regarding specific emerging technologies remain limited and, in some cases, data is inconclusive based on available public sources.

Geographic Footprint

DHC’s operations are primarily concentrated in the United States, with properties located across Northeast, Midwest, South, and West Coast regions. The trust’s headquarters is in Newton, Massachusetts, reflecting its historical roots and management structure. Its geographic diversification spans urban, suburban, and select secondary markets, providing exposure to varied demographic and economic conditions.

While DHC does not maintain significant direct international operations, its influence extends indirectly through tenants and operators with national or global healthcare platforms. The company’s life science and medical office assets are particularly concentrated in major U.S. healthcare and research hubs, including Massachusetts, California, and Texas, where demand for specialized healthcare real estate has been comparatively resilient.

Leadership & Governance

DHC is externally managed by The RMR Group, which shapes its governance structure and strategic execution. The leadership team emphasizes capital discipline, portfolio diversification, and long-term value creation through active asset management. Governance practices follow REIT regulatory standards, with oversight provided by an independent board of trustees.

Key executives include:

  • Christopher BilottoChief Executive Officer and President
  • Adam ChartierChief Financial Officer
  • Scott SewellChief Operating Officer
  • Jennifer FrancisChief Accounting Officer

Leadership has articulated a strategic vision focused on strengthening liquidity, reducing leverage, and repositioning the portfolio toward healthcare real estate segments with more stable demand characteristics.

Verification Requirements

All information presented is derived from publicly available disclosures, including SEC filings, company reports, and coverage by major financial publications. Where disclosures are limited or inconsistent across sources, the information has been presented conservatively. If specific details could not be confirmed across multiple reputable sources, data is inconclusive based on available public sources.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $167.52
B
AAPL NASDAQ $248.80
B
AVGO NASDAQ $300.68
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $122.89
B
Top Financial Stocks
See All »
B
B
JPM NYSE $282.84
B
V NYSE $295.52
Top Energy Stocks
See All »
Top Health Care Stocks
See All »
B
LLY NYSE $878.24
B
JNJ NYSE $240.45
B
AMGN NASDAQ $348.77
Top Real Estate Stocks
See All »
B
PLD NYSE $128.90